However, applying KAPAC to five normal and five glioblastoma tumor samples which showed most separable distributions of terminal exon lengths, we uncovered a pyrimidine motif, likely bound by PTBP1, as most significantly associated with changes in PAS use in these tumors. This evidence concerns the gene PTBP1 and neoplasm.